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In this study, we analyzed the replication and budding sites of severe acute respiratory syndrome coronavirus (SARS-CoV) at early time points
of infection. We detected cytoplasmic accumulations containing the viral nucleocapsid protein, viral RNA and the non-structural protein nsp3.
Using EM techniques, we found that these putative viral replication sites were associated with characteristic membrane tubules and double
membrane vesicles that most probably originated from ER cisternae. In addition to its presence at the replication sites, N also accumulated in the
Golgi region and colocalized with the viral spike protein. Immuno-EM revealed that budding occurred at membranes of the ERGIC (ER–Golgi
intermediate compartment) and the Golgi region as early as 3 h post infection, demonstrating that SARS-CoV replicates surprisingly fast. Our data
suggest that SARS-CoV establishes replication complexes at ER-derived membranes. Later on, viral nucleocapsids have to be transported to the
budding sites in the Golgi region where the viral glycoproteins accumulate and particle formation occurs.
© 2006 Elsevier Inc. All rights reserved.Keywords: SARS-coronavirus; Replication; Budding; Double membrane vesiclesIntroduction
SARS-coronavirus (SARS-CoV) is the etiologic agent of
severe acute respiratory syndrome (SARS) (Drosten et al., 2003;
Fouchier et al., 2003; Ksiazek et al., 2003; Kuiken et al., 2003;
Peiris et al., 2003). The virus belongs to the family of Corona-
viridae which are enveloped viruses with a positive-sense RNA
genome of about 30,000 nt length. Coronaviruses share a
common set of genes, encoding non-structural proteins (nsps)
involved in RNA replication (ORF 1a/1ab) and structural pro-
teins such as the nucleocapsid protein N, the membrane protein
M, the envelope protein E and the spike protein S. In addition,
there are several open reading frames with undefined or poorly
characterized functions, some of which also encode structural
proteins (Holmes, 1996; Navas-Martin and Weiss, 2004).⁎ Corresponding author. Fax: +49 761 2036562.
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doi:10.1016/j.virol.2006.11.027The Coronaviridae family consists of three phylogenetic
groups. Human pathogens are found in group I (229E andNL63)
and in group II (OC43 and HKU1). SARS-CoV constitutes
either a new phylogenetic group (Eickmann et al., 2003) or an
early split-off of group II (Snijder et al., 2003). Mouse hepatitis
virus (MHV), a member of group II, is the prototype coronavirus
used to study the cell biological aspects of replication and
assembly. ForMHVit was found that ORF 1a/1ab gene products
and the N protein colocalize with the viral RNA in cytoplasmic
complexes. These replication sites are associated with intracel-
lular membranes of characteristic shape. The formation of
double membrane vesicles (DMVs) was observed specifically in
infected cells (van der Meer et al., 1999; Gosert et al., 2002;
Brockway et al., 2003; Prentice et al., 2004a). However, the
origin of the membranes has not been clearly identified. It has
been suggested that MHV uses components of the cellular
autophagy machinery to form DMVs (Prentice et al., 2004a).
Autophagy is normally involved in the turnover of long-lived
proteins and damaged organelles (Stromhaug and Klionsky,
2001) and is part of the innate immune response (Levine, 2005).
Recently, it has been shown that the autophagy pathway can be
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Picorna- and Coronaviridae, to facilitate their replication
(Prentice et al., 2004a; Jackson et al., 2005). Assembly and
budding of new MHV particles take place in the pre-Golgi
compartment also called the ERGIC (ER–Golgi intermediate
compartment) (Tooze et al., 1984; Klumperman et al., 1994).
Therefore, it was speculated that viral genomic RNA and some
viral proteins, including nucleocapsid, have to translocate from
the RNA replication sites to the budding compartment at the
ERGIC (Bost et al., 2001). By contrast, other components of the
replication complex, such as the RNA-dependent RNA poly-
merase, stay associated with the viral replication sites through-
out the infection cycle (Brockway et al., 2003).
For SARS-CoV, the intracellular sites of replication and
budding have not been fully elucidated. With respect to viral
particle formation, it has been described that SARS-CoV bud-
ding occurs at a pre-Golgi compartment as well as at the outer
nuclear membrane 3–5 days post infection (p.i.) (Goldsmith et
al., 2004), whereas in another study virus particles budding into
the lumen of structures which resembled swollen Golgi cisternae
were detected already at 5 h p.i. (Ng et al., 2003).
Antibodies directed against the ORF 1a/1ab proteins of
SARS-CoVwere used to analyze the intracellular localization of
the viral replication sites. As described for other coronaviruses,
the non-structural proteins accumulated in discrete cytoplasmic
complexes (Harcourt et al., 2004; Ivanov et al., 2004; Prentice et
al., 2004b). In addition, SARS-CoV non-structural proteins
colocalized with LC3, a marker protein for autophagosomes,
reminiscent of the replication complexes ofMHV (Kabeya et al.,
2000; Prentice et al., 2004a, 2004b). However, ultrastructural
evidence supporting this conclusion has not been provided.
Moreover, it was demonstrated that the complexes containing
the non-structural proteins colocalized with newly synthesized
RNA on virus induced DMVs (Harcourt et al., 2004). While we
were preparing our manuscript, Snijder et al. published a study
on the ultrastructure of the SARS-CoV replication sites (Snijder
et al., 2006). They show colocalization of different SARS-CoV
non-structural proteins (nsp) at 9 h p.i. and the appearance of
putative viral replication sites associated with DMVs from 6 h p.
i. on. Interestingly, they observed ER membranes in vicinity to
the DMVs and found SARS-CoV nsps present at ER mem-
branes. However, direct evidence for the ER origin of the DMVs
was not provided.
The aim of our study was to further characterize both the
RNA replication site and the budding compartment of SARS-
CoV.We focused in our studies on early time points of infection,
reasoning that early in infection the ultrastructural architecture of
the cell might be better preserved. Using immunofluorescence
analysis and in situ hybridization, we could show that at early
time points after infection the viral nucleocapsid protein (SARS-
CoV N) accumulates in cytoplasmic complexes together with
viral genomic RNA and nsp3. We then investigated the ultra-
structure of these putative replication sites. Standard EM
revealed the presence of DMVs and characteristic membrane
tubules that protruded from ribosome-studded ER cisternae
already at 3 h p.i. Cryo-immuno-EM (iEM) confirmed that the
sites double positive for N and nsp3 labeling were associatedwith membrane tubules that originated from ER cisternae and
probably represent precursors of DMVs. The viral glycoprotein
SARS-CoV S, by contrast, was detected exclusively in the Golgi
area and was clearly distinct from the replication sites. Further
EM studies revealed that budding of SARS-CoV particles takes
place at the ERGIC and Golgi region. Therefore, we conclude
that genome replication and budding of SARS-CoV occur on
separate membrane-associated sites in the cytoplasm: ER
membranes are most likely used for the formation of replication
sites, whereas budding takes place at membranes in the ERGIC
and Golgi region. Strikingly, SARS-CoV runs through its
replication cycle very rapidly as budding was observed already
at 3 h p.i.
Results
Intracellular distribution of SARS-CoV N, SARS-CoV nsp3 and
SARS-CoV S early in infection
In a first set of experiments we analyzed the intracellular
localization of the SARS-CoV proteins N, nsp3 and S. The
nucleocapsid (N) protein of coronaviruses is involved in repli-
cation and transcription of the genome, but it is also a structural
component of the viral particle (Almazan et al., 2004; Schelle et
al., 2005). SARS-CoV nsp3 is a non-structural protein which
functions as a papain-like accessory proteinase (PLpro) (Thiel et
al., 2003; Harcourt et al., 2004). In addition, ADP-ribose-1″-
mono-phosphatase activity has been described for nsp3 (Putics
et al., 2005), and it has been shown that nsp3 is part of the viral
replication complex (Harcourt et al., 2004; Snijder et al., 2006).
The spike protein (S) is a structural protein present in the
membrane of viral particles. We generated specific antibodies, a
polyclonal rabbit serum and a mouse monoclonal antibody, both
specific for SARS-CoV N, and a monoclonal mouse antibody
against SARS-CoV S to determine the intracellular localization
of N and S during the course of infection. In addition, we
monitored nsp3 localization using an antibody described by
Harcourt et al. (2004). Vero cells were mock-infected or infected
with SARS-CoV for 3 h or 5 h, permeabilized and analyzed by
immunofluorescence. Anti-N staining revealed that as early as
3 h p.i., SARS-CoV N was detectable in small cytoplasmic foci
(Fig. 1b). At 5 h p.i. these foci had grown to large accumulations
and perinuclear enrichment of N became visible (Fig. 1c).
Staining against nsp3 resulted in a similar pattern at 3 h p.i. (Fig.
1e), but was different from the N distribution at 5 h (Fig. 1f):
Nsp3 was enriched in small cytoplasmic foci but no perinuclear
accumulation was observed. When cells were stained for SARS-
CoV S, we observed a different distribution: SARS-CoV S
became first detectable at 5 h p.i. and was found exclusively in
the perinuclear area (Fig. 1i).
Cytoplasmic accumulations of SARS-CoV N colocalize with
nsp3 and viral genomic RNA; perinuclear N colocalizes with
SARS-CoV S and a Golgi marker
Since the intracellular staining patterns of SARS-CoV N and
nsp3 were very similar at 3 h p.i., we double-stained for SARS-
Fig. 1. Distribution of SARS-CoV N, SARS-CoV nsp3 and SARS-CoV S at early time points of infection. Vero cells were either mock-infected (a, d, g) or infected
with SARS-CoV for 3 h (b, e, h) or 5 h (c, f, i) with an MOI of 10. Cells were fixed, permeabilized and analyzed by immunofluorescence using antibodies directed
against SARS-CoV N (a–c), SARS-CoV nsp3 (d–f) or SARS-CoV S protein (g–i). Scale bars represent 10 μm.
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colocalization of nsp3 and N in cytoplasmic foci at 3 h p.i.
Another study had shown that nsp3 colocalized with newly
synthesized viral RNA in SARS-CoV-infected cells and it was
suggested that the sites of nsp3 and RNA accumulation repre-
sented viral replication sites (Harcourt et al., 2004). Given the
role of N in coronavirus replication (Almazan et al., 2004;
Schelle et al., 2005), we investigated whether cytoplasmic N
foci also contained viral RNA. To this aim, Vero cells were
infected with SARS-CoV, fixed and analyzed by in situ
hybridization combined with immunofluorescence staining of
the viral N protein. For the detection of viral RNA, an FITC-
labeled RNA probe which hybridizes to the SARS-CoV nsp1-
ORF was used. The nsp1-ORF is located at the 5′ end of the
viral genome and is therefore only present on the full-length
genomic RNA of SARS-CoV. Thus, our probe of negative
polarity should detect full-length viral RNA of positive polarity.
When the probe was tested on mock-infected cells, no signal
was detected, confirming the specificity of the RNA probe (data
not shown). In SARS-CoV-infected cells, at 5 h p.i. clear signals
for viral RNA were detected (Fig. 2d), whereas at earlier time
points viral RNA-specific labeling could not be observed (datanot shown). When the cells were examined in parallel for
expression of the viral N protein (Fig. 2e), it turned out that
accumulations of the N protein colocalized with sites of strong
viral RNA signals (Fig. 2f). Additional diffuse cytoplasmic N
staining that did not colocalize with viral RNAwas also evident,
most likely representing newly synthesized free N protein. It
should be mentioned that the distribution of N in Fig. 2e was
slightly different than in Figs. 2h and k: more diffuse N staining
throughout the cytoplasm was visible in Fig. 2e. This might be
explained by the different fixation procedure used for in situ
hybridization. Next, we compared the signals for the viral
nucleoprotein N and the viral glycoprotein S at 5 h p.i. by
double-immunostaining since we had observed perinuclear
accumulation of both proteins. Indeed, colocalization of SARS-
CoV N with SARS-CoV S was observed in the perinuclear area,
whereas the N signals in the peripheral dots were clearly distinct
from the S glycoprotein-positive area (Figs. 2g–i). When we
stained for the Golgi marker protein Giantin in parallel, we
found a clear colocalization of the perinuclear N and S con-
taining accumulations with Giantin (Figs. 2j–l and data not
shown). In contrast, staining for nsp3 resulted in no overlap
with staining either for S or the Golgi marker (data not shown).
Fig. 2. Cytoplasmic accumulations of SARS-CoV N colocalize with nsp3 and viral genomic RNA; perinuclear N colocalizes with S and a Golgi marker. (a–c) Vero
cells were infected with SARS-CoV (MOI of 10) for 3 h, fixed and stained with specific antibodies for SARS-CoV nsp3 (a, green) and N (b, red) in parallel. (d–f) Vero
cells were infected with SARS-CoV (MOI of 10) for 5 h, fixed and in situ hybridization was performed with a FITC-labeled RNA probe of negative polarity directed
against the nsp1-ORF (d, green). After in situ hybridization, immunofluorescence staining was performed with an antibody specific for SARS-CoV N (e, red). (g–l)
Vero cells were infected with SARS-CoV (MOI of 10) for 5 h, fixed, permeabilized and stained with antibodies specific for SARS-CoV S or Giantin, a marker for cis-
Golgi, (g, j, green) and SARS-CoV N (h, k, red). Areas of colocalization appear in yellow in the merged images (c, f, i, l). Scale bars represent 10 μm.
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that as early as 3 h p.i., cytoplasmic accumulations of SARS-
CoV N which colocalize with SARS-CoV nsp3 and viral
genomic RNA are formed in infected cells. These cytoplasmic
foci most probably represent viral replication sites, a hypothesis
which is supported by the results of two other studies (Harcourt
et al., 2004; Snijder et al., 2006). From 5 h p.i. on, N staining
also became visible in the perinuclear area colocalizing with S
and a Golgi marker whereas nsp3 was clearly excluded from
these sites. This suggested that the N- and S-double-positive
areas represent assembly and budding sites.Budding of SARS-CoV takes place in the Golgi region already
at 3 h p.i
To analyze budding of SARS-CoV, we performed standard
EM, which is well suitable for the detection of virus particles.
Surprisingly, we found viral particles already at 3 h p.i. in
Golgi cisternae and vesicles close to the Golgi (Fig. 3b, large
arrows), whereas no viral structures could be detected in
uninfected cells (Fig. 3a). At 5 h p.i. many particles were
found throughout the cell (Figs. 3c, d). The budding and
presence of numerous SARS-CoV particles in Golgi cisternae
Fig. 3. Budding of SARS-CoVoccurs in the ERGIC and Golgi area already at 3 h p.i. (a–d) Vero cells were mock-infected (a) or infected with SARS-CoV (MOI of 10)
for 3 h (b) or 5 h (c, d), fixed and analyzed by standard EM. The nuclei are marked with “Nu” and the Golgi with “G”. Viral particles are highlighted with arrows (b–d).
Scale bars represent 200 or 500 nm as indicated. (e, f) Vero cells were infected with SARS-CoV (MOI of 10) for 3 h, fixed and analyzed by cryo-iEM with antibodies
directed against SARS-CoV N (10 nm gold, filled arrowheads) and β′COP-I as a marker for the ERGIC and Golgi area (15 nm gold, open arrowheads). Budding
profiles are marked with small arrows, large arrows point to viral particles. Scale bars represent 100 nm.
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represent virus inoculum. As an additional control we also
infected Vero cells with UV-irradiated SARS-CoV. In contrast
to infection with native virus, viral particles were not
detectable in these samples (data not shown). For other
coronaviruses it was shown that budding takes place in the
ERGIC (Tooze et al., 1984; Klumperman et al., 1994). To gain
insights into the assembly and budding sites of SARS-CoV,
we performed immuno-EM (iEM) studies. Unfortunately, the
antibody specific for S was not suitable for iEM. We thereforeused an N-specific antibody to label viral budding profiles and
particles. Additionally, cryosections were labeled with an
antibody specific for β′COP-I, a well established marker for
the ERGIC and Golgi region (Lowe and Kreis, 1995). We
found a clear colocalization of N (Figs. 3e, f, filled arrow-
heads) with the β′COP-I marker (Figs. 3e, f, open arrow-
heads) indicating accumulation of N in the ERGIC and Golgi
region. Again, as early as 3 h p.i. we observed partially
enveloped N-containing structures of approximately the size of
virions, most likely representing budding particles (Figs. 3e, f,
309S. Stertz et al. / Virology 361 (2007) 304–315small arrows) as well as completely budded particles (Figs. 3e,
f, large arrows). This strongly suggests that budding of
SARS-CoV particles takes place in the ERGIC and Golgi
area. It should be noted that we observed SARS-CoV
particles by EM at a time point when we could not observe
SARS-CoV N and SARS-CoV S accumulation in the Golgi
by immunofluorescence staining. This may be explained by
the much higher sensitivity of EM which enabled us to detect
newly formed SARS-CoV particles at the ultrastructural level
even at 3 h p.i.Fig. 4. Ultrastructural analysis of the putative SARS-CoV replication sites. (a, b) Vero
fixed and analyzed by standard EM. Double membrane vesicles characteristic for S
infected with SARS-CoV (MOI of 10) for 3 h, fixed and analyzed by cryo-iEM. Cells
arrowheads) and SARS-CoV nsp3 (5 nm gold, open arrowheads). Areas of colocaliz
these sites are marked with arrows. Sites where viral particles (marked with stars) we
represent 200 or 500 nm as indicated.Ultrastructural analysis of the putative SARS-CoV replication
sites
Our immunofluorescence studies had suggested that viral
replication sites were formed already at 3 h p.i. To confirm this,
we analyzed cells infected with SARS-CoV by standard EM.
Harcourt et al. had described characteristic DMVs in SARS-
CoV-infected cells representing viral replication sites (Harcourt
et al., 2004). Indeed, we readily found DMVs in infected cells at
3 h p.i. (Fig. 4b) but not in mock-infected cells (Fig. 4a). Thecells were mock-infected (a) or infected with SARS-CoV (MOI of 10) for 3 h (b),
ARS-CoV replication sites are highlighted with arrows. (c–e) Vero cells were
were labeled with antibodies directed against SARS-CoV N (15 nm gold, filled
ation of N and nsp3 are shown in panels c and d. Membrane tubules specific for
re present only contained N labeling but almost no nsp3 labeling (e). Scale bars
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between the two opposing membranes was about 15 nm. Next,
we performed cryo-iEM to further characterize viral replication
sites. Thawed cryosections of cells infected with SARS-CoV for
3 h were labeled with antibodies specific for SARS-CoV N or
nsp3. The specificity of both antibodies in cryo-iEM was
controlled with mock-infected cells where almost no signal was
detected (data not shown). N and nsp3 were visible in cyto-
plasmic foci (Figs. 4c, d) which were clearly distinct from the
Golgi-associated budding sites and most probably correspond to
the putative replication sites identified by immunofluorescence
and in situ hybridization (Fig. 2). As shown above (Fig. 3), the
N-specific labeling was also associated with budding viral
particles in the Golgi area. In this region almost no nsp3 labeling
was found indicating the absence of replication sites from the
Golgi region (Fig. 4e). Most interestingly, we observed charac-teristic membrane tubules of about 15 nm in diameter within the
N/nsp3 accumulations (marked with arrows in Fig. 4d) that
were not found in mock-infected cells. As we frequently found
ER cisternae in close proximity to the N/nsp3 double positive
sites, we postulated that the specific membrane tubules were
derived from ER cisternae. In line with this hypothesis we found
enrichment of an ER marker protein at the N/nsp3 double
positive sites in immunofluorescence studies (data not shown).
Membrane tubules within the SARS-CoV replication sites are
derived from ER membranes
In order to further analyze the association of viral replication
sites with ER membranes, we performed an ultrastructural
analysis of both non-infected and infected cells using a
combination of immuno- and standard EM techniques. At 3 h
Fig. 5. Membrane tubules within the SARS-CoV replication sites are derived from ER membranes. A) Vero cells were mock-infected (a) or infected with SARS-CoV
(MOI of 10) for 3 h (b, c), fixed and analyzed by standard EM. ER cisternae are marked with large arrows, whereas the double membrane vesicles and the membrane
tubules characteristic for the putative replication sites are highlighted with small arrows. Scale bars represent 200 nm or 500 nm as indicated. B) Vero cells were mock-
infected (a) or infected with SARS-CoV (MOI of 10) for 3 h (b–e), fixed and analyzed by cryo-iEM. Cells were labeled with antibodies directed against SARS-CoV N
(a–c, 10 nm gold, filled arrowheads) or SARS-CoV nsp3 (d–e, 15 nm gold, filled arrowheads) and PDI as a marker for ER (a–e, 5 nm gold, open arrowheads). Panel B
c and e show putative replication complexes in a higher magnification. PDI labeling surrounded the N assembly in c but is not visible in this cutout. ER cisternae are
marked with large arrows (a, b) and small arrows delineate membrane tubules characteristic for the putative replication sites (b, c). Scale bars represent 200 nm.
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standard embedding in epoxy-resin (Fig. 5A) or cryosectioning
(Fig. 5B). First, we analyzed conventionally embedded control
and infected cells, reasoning that in these preparations double
membrane vesicles and ER membranes might be well pre-
served. As shown in Fig. 4b, DMVs were readily found in
SARS-CoV-infected cells at 3 h p.i. (Figs. 5Ab, c) but were only
rarely detected in mock-infected cells (Fig. 5Aa). Furthermore,
thin membrane tubules that protruded from ribosome-studded
ER cisternae were also observed (Figs. 5Ab, c). These structures
were of about 10 to 20 nm in diameter and were closely
associated with the DMVs. The consistent finding of concen-
trically arranged, curved or nearly closed tubules together with
double membrane vesicles strongly suggests that the latter
structures are derived from tubular ER-protrusions. To confirmER origin of the characteristic membrane tubules, we next
performed cryo-iEM. Thawed cryosections were labeled with
antibodies specific for SARS-CoV N and protein disulfide
isomerase (PDI), a well established marker for the ER that
labels specifically the lumen of ER cisternae. The specificity of
the double-immunogold labeling was controlled with sections
of mock-infected cells (Fig. 5Ba). The lumen of the ER cis-
ternae (Fig. 5B, large arrows) was specifically labeled with the
anti-PDI antibody (Fig. 5B, open arrowheads) in both control
cells (Fig. 5Ba) and infected cells (Fig. 5Bb). Incubation of
sections with the anti-N antibody did hardly lead to any
immunogold labeling in mock-infected but clear signals in
infected cells, confirming its specificity and excluding any
crossreaction with the anti-PDI antibody (Fig. 5B, filled
arrowheads). The membrane tubules associated with the
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specific tubules observed in conventionally embedded sections
(compare Figs. 5A and B) and indeed originated from PDI-
positive ER cisternae (Fig. 5Bb, small arrows). When sections
were labeled with an nsp3-specific antibody in combination
with the anti-PDI antibody, both labels were found clustering
together at the edge of extracted sites in the cytoplasm which
probably correspond to DMVs (Figs. 5Bd, e). Although in this
case the specific membrane tubules were not as clearly visible
as in Figs. 5Bb and c, the nsp3–PDI labeling confirmed the
association of the replication sites with the ER. Therefore, one
can summarize that the putative viral RNA replication sites
comprise distinct ER-derived membrane protrusions that
specifically occur in infected cells and were never observed in
control cells. In ultrathin sections (60–70 nm) that merely allow
a two-dimensional view of three-dimensional structures, these
protrusions appeared as tubule-like structures of about 10–
20 nm (Figs. 5Bb, c, small arrows). It is very likely that these
structures in fact represent flat ER-derived double membrane
sheets when seen in three dimensions. This assumption is
supported by the lack of vesicular structures of the same
diameter that would represent cross-sectioned tubules. These
ER-derived protrusions were strongly curved, suggesting that
they are precursors of DMVs formed at the viral replication
sites.
Additionally, we compared the localization of the autopha-
gosomal marker LC3 with the distribution of N in SARS-CoV-
infected cells by immunofluorescence analysis, as it has been
suggested that autophagy might play a role in the formation of
the viral replication sites (Prentice et al., 2004b). Using an
LC3-specific antiserum, we found partial colocalization of N
and LC3 at 3 h and 5 h p.i. (Supplementary Figs. 1a–f). How-
ever, when we used a plasmid encoding GFP-LC3 (Mizushima
et al., 2004) we could not observe any colocalization of N
and LC3 (Supplementary Figs. 1g–i) or nsp3 and LC3 (data not
shown). Thus, further studies are required to determine the
role of autophagy in the formation of SARS-CoV replication
sites.
Discussion
In this study, we investigated cell biological aspects of the
replication cycle of SARS-CoV by analyzing the intracellular
localization of viral proteins. We found cytoplasmic accumula-
tions of SARS-CoV N and nsp3 as early as 3 h p.i. and
colocalization of N with viral genomic RNA at 5 h p.i.
Cytoplasmic accumulations of the non-structural protein nsp3
which colocalized with other non-structural proteins and newly
synthesized RNA have been described before, and it was
suggested that these accumulations are the SARS-CoV
replication sites (Harcourt et al., 2004; Snijder et al., 2006).
Since we found colocalization of N with nsp3 as well as with
viral genomic RNA, this strongly suggests that the N assemblies
represent the replication sites of SARS-CoV. Interestingly, we
also found colocalization of these putative replication sites with
a marker protein for the ER, and indeed ultrastructural analysis
proved that the N assemblies were associated with distinctmembrane protrusions that are continuous with and thus most
probably originate from ER cisternae. Therefore, we hypoth-
esize that SARS-CoV recruits membranes from the ER to build
the sites of viral replication. Recently, Prentice et al. described
cytoplasmic foci in SARS-CoV-infected cells that were positive
for proteins encoded by ORF 1a/1ab and also for the auto-
phagosomal marker LC3 (Prentice et al., 2004b). In analogy to
MHV, it was suggested that these foci are RNA replication
complexes associated with membranes of autophagosomes. In
the case of MHV it was shown that autophagy is induced by
infection and plays an important role for viral replication
(Prentice et al., 2004a). We also compared the localization of
LC3 with the N accumulations by using an LC3-specific
antibody and found colocalization of N and LC3 to some extent.
However, using a plasmid encoding GFP-LC3 we got a diffe-
rent result: no overlap of the N- and LC3-specific staining was
detected confirming a recent study by Snijder et al. (2006).
Thus, the role of autophagy in the formation of SARS-CoV
replication sites still needs to be elucidated. During the process
of autophagy, cytoplasmic material is engulfed by membranes
that are thought to be derived from the ER or formed de novo,
leading to the formation of DMVs (Klionsky and Emr, 2000;
Kirkegaard et al., 2004). Indeed, drastic membrane rearrange-
ments, especially DMVs, were described to be associated with
the replication complexes of the coronavirus MHV (Gosert et
al., 2002) and the arterivirus equine arteritis virus (Pedersen
et al., 1999). Accordingly, we also found formation of DMVs
in SARS-CoV-infected cells in line with two recent studies
(Goldsmith et al., 2004; Snijder et al., 2006). We provide
morphological evidence that the ER-derived membrane pro-
trusions associated with the putative replication complexes are
the precursors of the DMVs. Therefore, we conclude that the
formation of DMVs in SARS-CoV-infected cells occurs by
curving and fusion of ER-derived double membrane sheets.
This is consistent with the protrusion-and-detachment model
for the formation of DMVs in arterivirus-infected cells
(Pedersen et al., 1999).
Earlier studies demonstrated the appearance of viral replicase
components at 4 h p.i. in SARS-CoV-infected cells (Harcourt et
al., 2004) and release of viral particles from infected cells at 5 h
p.i. (Ng et al., 2003), already suggesting that SARS-CoV is a
very fast replicating virus. Indeed, using immunofluorescence
we found colocalization of N and S with a Golgi marker indi-
cating budding events from 5 h p.i. on. Strikingly, using EM we
observed newly formed SARS-CoV particles in the Golgi even
at 3 h p.i. Importantly, budding profiles and viral particles were
strongly labeled with the N-specific antibody, but nsp3 labeling
was only rarely associated with the budding sites. This confirms
our immunofluorescence data which had shown that nsp3 stays
associated with the replication sites and was absent from S
accumulations. We detected budding of viral particles into β′
COP-I-positive membranes of the ERGIC and Golgi area,
which is in line with the finding of another study that SARS-
CoV particles bud into membranes of the pre-Golgi compart-
ment (Goldsmith et al., 2004). However, in the same study
additional particle formation at the outer nuclear membrane was
observed at 3 days p.i., an effect which might occur late in
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viral proteins and viral genomic RNA. In another study,
budding into vacuoles, supposed to be derived from the Golgi,
was described (Ng et al., 2003). Indeed, we detected similar
vacuoles containing multiple particles from 7 h p.i. on (data not
shown) and also observed some budding profiles at these
vacuoles. However, we found that the Golgi area is the main
budding site of SARS-CoV early in infection. Budding is
probably a very rapid process, and the newly formed particles
are directly transported to the cis-Golgi. This would explain
why we see a prominent accumulation of SARS-CoV N and S
in the cis-Golgi with immunofluorescence analysis.
In summary, our results support the following model for the
replication cycle of SARS-CoV: early in infection, viral
replication complexes are established at ER-derived membranes
that are transformed into characteristic DMVs by drastic mem-
brane rearrangements. The possible involvement of autophagy
as well as the role of single viral proteins in this process has
to be addressed in future studies. Later on, viral genomic
RNA and N protein translocate to the budding sites at the
ERGIC and Golgi region, where the viral glycoproteins are
located and budding of new particles occurs. Intriguingly,
SARS-CoV passes through these different steps of the repli-
cation cycle very fast as we observed the final step, budding,
already at 3 h p.i.
Materials and methods
Cells and viruses
African green monkey kidney (VeroE6) cells were main-
tained in DMEM supplemented with 10% fetal calf serum and
antibiotics. The FFM-1 strain of SARS-CoV was kindly
provided by Stephan Becker, Robert-Koch-Institut, Berlin,
Germany (Drosten et al., 2003).
Antibodies and plasmids
For detection of SARS-CoV N, a rabbit polyclonal antiserum
(Spiegel et al., 2005) and a mouse monoclonal antibody were
used. To generate the mouse monoclonal antibody, mice were
immunized with bacterially expressed recombinant SARS-CoV
N (Spiegel et al., 2005). Briefly, 100 μg of purified SARS-CoV
N dissolved in complete Freund's adjuvant was used to
immunize BALB/c mice. Two weeks after immunization,
mice were boosted with the same dose and 2 weeks later,
splenocytes from one mouse were fused with SP2 cells to
generate hybridomas. Hybridoma supernatants were screened
on 96-well plates coated with the bacterially expressed SARS-
CoV N, and specific monoclonal antibodies were selected. The
specificity of all monoclonal antibodies was confirmed by
immunofluorescence and Western blot analyses using cells
transfected with a SARS-CoV N expression plasmid and in
SARS-CoV-infected cells. In this study, we used the monoclo-
nal antibody 9C10, one of the selected clones. We also gene-
rated a mouse monoclonal antibody against SARS-CoV S. To
this aim, the S cDNA sequence (Urbani strain) was first clonedinto the expression vector pCAGGS by using EcoRI and XhoI
restriction endonucleases. Reverse transcriptase PCR (RT-PCR)
was done by using RNA from SARS-CoV-infected cells, kindly
provided by Dr. Paragas (USAMRIID, Fort Detrick). SARS-
CoV S cDNAwas cloned into pRB21 to generate a recombinant
vaccinia virus expressing SARS-CoV S (rVV-S) as described
(Blasco and Moss, 1995). To generate monoclonal antibodies,
one mouse was immunized with 106 pfu of the rVV-S. Two
weeks after rVV-S immunization, the mouse was boosted with
recombinant SARS-CoV S fragments produced in bacteria.
Purified GST-S fragment F2 (aa 258 to 572) and GST-S
fragment F3 (aa 492 to 856) were administrated intravenously.
Two weeks after boosting, splenocytes were fused with SP2
cells, and hybridomas were screened for their ability to generate
antibodies which specifically recognize Vero cells transfected
with the pCAGGS-SARS-CoV S expression vector. One of
the selected SARS-CoV S specific monoclonal antibodies,
5E5G10, was used in this study. To detect SARS-CoV nsp3,
we used a polyclonal rabbit serum (Harcourt et al., 2004),
kindly provided by S. Baker, Loyola University of Chicago,
Illinois. A monoclonal mouse anti-Giantin antibody to stain
the cis-Golgi (Linstedt and Hauri, 1993) was kindly provided
by H.P. Hauri, Biozentrum Basel, Switzerland. The polyclonal
rabbit anti-PDI antibody was purchased from Santa Cruz
Biotechnology (California, U.S.) and a polyclonal rabbit anti-
serum directed against β′COP-I was provided by J. Simpson,
EMBL, Heidelberg, Germany (Lowe and Kreis, 1995). A
polyclonal rabbit antiserum directed against LC3 (Kabeya et al.,
2000) and the plasmid pEGFP-LC3 (Mizushima et al., 2004)
which were both used to label autophagosomes were gifts
from T. Yoshimori, National Institute of Genetics, Shizuoka,
Japan.
Infection
Vero cells were incubated with SARS-CoV in DMEM with
2% fetal calf serum for 1 h. Subsequently, the inoculum was
washed off and cells were incubated with DMEM containing
10% fetal calf serum. Infection experiments were performed
under biosafety level 3 conditions.
Immunofluorescence analysis
Vero cells grown on glass cover slips were infected with
SARS-CoV at an MOI of 10. When studying the localization
of GFP-LC3, cells were transfected with 0.5 μg plasmid per
well of a 6-well-plate using Metafectene (Biontex, Munich,
Germany) according to the manufacturer's protocol 24 h
before infection. At the time points indicated, cells were fixed
with 3% paraformaldehyde and then permeabilized with 0.5%
Triton-X-100 in phosphate-buffered saline (PBS). Cells were
stained for viral proteins and intracellular compartments using
specific primary antibodies and subsequently fluorophore
(Cy2, Cy3)-conjugated donkey secondary antibodies (Dianova,
Hamburg, Germany). Immunostained cells were analyzed with
a Leica (Heidelberg, Germany) TCSSP2 confocal laser scan-
ning microscope.
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cDNA encoding the nsp1-ORF (nt 265–801 of the SARS-
CoV genome) of SARS-CoV was cloned into the pcDNA 3.1
TOPO TA cloning vector (Invitrogen) using the following pri-
mers: 5′tctagaatggagagccttgttcttggtgtcaacgagaaaa3′ and 5′
ctcgagtcatccattgagctcacgagtgagtt3′. For in vitro transcription,
the cDNA was cloned into pBSK(I) using BamHI and EcoRV
restriction enzymes. The plasmid was linearized, and a ribop-
robe of negative polarity was prepared by in vitro transcription
with T7 RNA polymerase in the presence of fluorescein
isothiocyanate (FITC)-labeled UTP (Roche, Mannheim, Ger-
many). To detect viral RNA in infected cells, Vero cells grown
on cover slips were infected with SARS-CoV using an MOI of
10 and fixed with 3% paraformaldehyde at 5 h p.i. In situ
hybridization and subsequent immunofluorescence staining
were performed as described (Bolten et al., 1998; Egger et al.,
1999).
Electron microscopy (EM)
The samples were either processed for standard electron
microscopy (standard EM) (Luft, 1961) or cryo-immuno-EM
(cryo-iEM). In brief, for standard EM cells were fixed in
phosphate-buffered 1% glutaraldehyde, pH 7.2 and postfixed in
1% osmium tetroxide. The samples were then dehydrated in a
graded ethanol series and propylene oxide and finally
embedded in epoxy-resin EMbed-812 (EMS, Electron Micros-
copy Sciences). Ultrathin sections (60 nm) were cut on an
Ultracut S ultramicrotome (Leica), mounted on Formvar- and
carbon-coated grids and counterstained with 1% aqueous uranyl
acetate and 0.2% lead citrate. Processing for cryo-iEM and
immunogold labeling were performed essentially as described
before (Reichelt et al., 2004). Samples were fixed in phosphate-
buffered 0.2% glutaraldehyde, pH 7.2 and 2% paraformalde-
hyde, embedded in 10% gelatin and infiltrated with 2.3 M
sucrose overnight. Sample blocks were mounted on cryoul-
tramicrotomy pins and frozen in liquid nitrogen. Ultrathin
sections (70 nm) were cut on an Ultracut Cryoultramicrotome
(Leica) at −125 °C, picked up with a mixture (1:1) of 2%
methylcellulose and 2.3 M sucrose and transferred to Formvar-
and carbon-coated grids. Immunogold double-labeling was
performed essentially as described (Slot et al., 1991). First, the
specificity of the antibodies used (anti-β′COP I, anti-PDI, anti-
nsp3, anti-N) was controlled by single-immunogold labeling.
To detect the primary antibodies we used Protein A conjugated
with colloidal gold (PA–gold) of different sizes (5 nm, 10 nm or
15 nm). Double-labeling was performed by incubating with the
first antibody and detection with PA–gold, then fixation with
1% GA for 5 min, quenching and incubation with the second
antibody and detection with PA–gold of a different size. Finally,
sections were counterstained with 0.5% uranyl acetate in 2%
methylcellulose for 10 min on ice and grids were looped out to
dry. Samples were analyzed with a Philips 400 electron micro-
scope or with a JEOL 1230 TEM at 80 kV, and digital
photographs were taken using a Gatan Multiscan 791 digital
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